Bristol Myers to buy Cambridge startup Orbital Therapeutics, building out cell therapy pipeline – The Boston Globe
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…
Bristol Myers Squibb said Friday that it would buy Cambridge startup Orbital Therapeutics for $1.5 billion in cash, the latest…